Phosphotransferases (Alcohol Group Acceptor)
"Phosphotransferases (Alcohol Group Acceptor)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.
| Descriptor ID |
D017853
|
| MeSH Number(s) |
D08.811.913.696.620
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phosphotransferases (Alcohol Group Acceptor)".
Below are MeSH descriptors whose meaning is more specific than "Phosphotransferases (Alcohol Group Acceptor)".
This graph shows the total number of publications written about "Phosphotransferases (Alcohol Group Acceptor)" by people in this website by year, and whether "Phosphotransferases (Alcohol Group Acceptor)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 5 | 2 | 7 |
| 1995 | 6 | 1 | 7 |
| 1996 | 2 | 0 | 2 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 2 | 5 |
| 1999 | 1 | 1 | 2 |
| 2000 | 3 | 0 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 4 | 5 |
| 2008 | 4 | 2 | 6 |
| 2009 | 3 | 4 | 7 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 1 | 5 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphotransferases (Alcohol Group Acceptor)" by people in Profiles.
-
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. J Infect Dis. 2024 Feb 14; 229(2):413-421.
-
Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis. Cell Mol Immunol. 2022 10; 19(10):1153-1167.
-
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition. Neoplasia. 2022 01; 24(1):1-11.
-
PIGG variant pathogenicity assessment reveals characteristic features within 19 families. Genet Med. 2021 10; 23(10):1873-1881.
-
Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis. Proc Natl Acad Sci U S A. 2020 04 07; 117(14):8154-8165.
-
PI4KIII? is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med. 2020 01 22; 12(527).
-
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease. Blood. 2020 01 02; 135(1):28-40.
-
The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma. EMBO Mol Med. 2019 12; 11(12):e10849.
-
Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells. Oncogene. 2020 01; 39(4):801-813.
-
Incidence of PKAN determined by bioinformatic and population-based analysis of ~140,000 humans. Mol Genet Metab. 2019 12; 128(4):463-469.